|
1
|
Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo
IM, Halepoto DM, Iqbal M, Usmani AM, Hajjar W and Ahmed N: Novel
coronavirus 2019-nCoV: Prevalence, biological and clinical
characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med
Pharmacol Sci. 24:2012–2019. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hui DS, Memish ZA and Zumla A: Severe
acute respiratory syndrome vs. the Middle East respiratory
syndrome. Curr Opin Pulm Med. 20:233–241. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen J: Pathogenicity and transmissibility
of 2019-nCoV-A quick overview and comparison with other emerging
viruses. Microbes Infect. 22:69–71. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from
patients with pneumonia in China, 2019. N Engl J Med. 382:727–733.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kannan S, Shaik Syed Ali P, Sheeza A and
Hemalatha K: COVID-19 (Novel Coronavirus 2019)-recent trends. Eur
Rev Med Pharmacol Sci. 24:2006–2011. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu YC, Chen CS and Chan YJ: The outbreak
of COVID-19: An overview. J Chin Med Assoc. 83:217–220.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu W, Wu J and Cao L: COVID-19 pandemic in
China: Context, experience and lessons. Health Policy Technol.
9:639–648. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sookaromdee P and Wiwanitkit V: Imported
cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand:
Mathematical modelling of the outbreak. Asian Pac J Trop Med.
13(139)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Harapan H, Itoh N, Yufika A, Winardi W,
Keam S, Te H, Megawati D, Hayati Z, Wagner AL and Mudatsir M:
Coronavirus disease 2019 (COVID-19): A literature review. J Infect
Public Health. 13:667–673. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Benvenuto D, Giovanetti M, Salemi M,
Prosperi M, De Flora C, Junior Alcantara LC, Angeletti S and
Ciccozzi M: The global spread of 2019-nCoV: A molecular
evolutionary analysis. Pathog Glob Health. 114:64–67.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhou P, Yang XL, Wang XG, Hu B, Zhang L,
Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak
associated with a new coronavirus of probable bat origin. Nature.
579:270–273. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Coronaviridae Study Group of the
International Committee on Taxonomy of Viruses. The species Severe
acute respiratory syndrome-related coronavirus: Classifying
2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 5:536–544.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Schoeman D and Fielding BC: Coronavirus
envelope protein: Current knowledge. Virol J. 16(69)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and
epidemiology of 2019 novel coronavirus: Implications for virus
origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lai CC, Shih TP, Ko WC, Tang HJ and Hsueh
PR: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and coronavirus disease-2019 (COVID-19): The epidemic and the
challenges. Int J Antimicrob Agents. 55(105924)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
da Silva SJR, Silva CTAD, Guarines KM,
Mendes RPG, Pardee K, Kohl A and Pena L: Clinical and laboratory
diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infect
Dis. 6:2319–2336. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT
and Chaillon A: Evolutionary history, potential intermediate animal
host, and cross-species analyses of SARS-CoV-2. J Med Virol.
92:602–611. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chan JF, Yip CC, To KK, Tang TH, Wong SC,
Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, et al: Improved molecular
diagnosis of COVID-19 by the novel, highly sensitive and specific
COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain
reaction assay validated in vitro and with clinical specimens. J
Clin Microbiol. 58:e00310–20. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai
FH, Wu F, Song ZG, Huang W, Chen J, et al: Persistence and
clearance of viral RNA in 2019 novel coronavirus disease
rehabilitation patients. Chin Med J (Engl). 133:1039–1043.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Phan T: Genetic diversity and evolution of
SARS-CoV-2. Infect Genet Evol. 81(104260)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang
L, Zhou Z, Yang J, Zhong J, Yang D, et al: Genomic diversity of
severe acute respiratory syndrome-coronavirus 2 in patients with
coronavirus disease 2019. Clin Infect Dis. 71:713–720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tahamtan A and Ardebili A: Real-time
RT-PCR in COVID-19 detection: Issues affecting the results. Expert
Rev Mol Diagn. 20:453–454. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM,
Chung YS, Kim HM, Han MG, Kim SY and Chin BS: Viral load kinetics
of SARS-CoV-2 infection in first two patients in Korea. J Korean
Med Sci. 35(e86)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bustin SA and Nolan T: RT-qPCR testing of
SARS-CoV-2: A primer. Int J Mol Sci. 21(3004)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Robbiani DF, Gaebler C, Muecksch F,
Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A,
Finkin S, et al: Convergent antibody responses to SARS-CoV-2 in
convalescent individuals. Nature. 584:437–442. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Stadlbauer D, Amanat F, Chromikova V,
Jiang K, Strohmeier S, Arunkumar GA, Tan J, Bhavsar D, Capuano C,
Kirkpatrick E, et al: SARS-CoV-2 seroconversion in humans: A
detailed protocol for a serological assay, antigen production, and
test setup. Curr Protoc Microbiol. 57(e100)2020.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Amanat F, Stadlbauer D, Strohmeier S,
Nguyen THO, Chromikova V, McMahon M, Jiang K, Arunkumar GA,
Jurczyszak D, Polanco J, et al: A serological assay to detect
SARS-CoV-2 seroconversion in humans. Nat Med. 26:1033–1036.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Van Elslande J, Houben E, Depypere M,
Brackenier A, Desmet S, André E, Van Ranst M, Lagrou K and
Vermeersch P: Diagnostic performance of seven rapid IgG/IgM
antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19
patients. Clin Microbiol Infect. 26:1082–1087. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zainol Rashid Z, Othman SN, Abdul Samat
MN, Ali UK and Wong KK: Diagnostic performance of COVID-19 serology
assays. Malays J Pathol. 42:13–21. 2020.PubMed/NCBI
|
|
30
|
Guo L, Ren L, Yang S, Xiao M, Chang D,
Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al: Profiling early
humoral response to diagnose novel coronavirus disease (COVID-19).
Clin Infect Dis. 71:778–785. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhu Y, Liu YL, Li ZP, Kuang JY, Li XM,
Yang YY and Feng ST: Clinical and CT imaging features of 2019 novel
coronavirus disease (COVID-19). J Infect: Mar 3, 2020 doi:
10.1016/j.jinf.2020.02.022 (Epub ahead of print).
|
|
32
|
Xie C, Jiang L, Huang G, Pu H, Gong B, Lin
H, Ma S, Chen X, Long B, Si G, et al: Comparison of different
samples for 2019 novel coronavirus detection by nucleic acid
amplification tests. Int J Infect Dis. 93:264–267. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ye Z, Zhang Y, Wang Y, Huang Z and Song B:
Chest CT manifestations of new coronavirus disease 2019 (COVID-19):
A pictorial review. Eur Radiol. 30:4381–4389. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Franquet T: Imaging of pulmonary viral
pneumonia. Radiology. 260:18–39. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Song F, Shi N, Shan F, Zhang Z, Shen J, Lu
H, Ling Y, Jiang Y and Shi Y: Emerging 2019 novel coronavirus
(2019-nCoV) pneumonia. Radiology. 295:210–217. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Pan F, Ye T, Sun P, Gui S, Liang B, Li L,
Zheng D, Wang J, Hesketh RL, Yang L and Zheng C: Time course of
lung changes at chest CT during recovery from coronavirus disease
2019 (COVID-19). Radiology. 295:715–721. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim
KH, Park CM and Kim YH: Chest radiographic and CT findings of the
2019 novel coronavirus disease (COVID-19): Analysis of nine
patients treated in Korea. Korean J Radiol. 21:494–500.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hansell DM, Bankier AA, MacMahon H, McLoud
TC, Müller NL and Remy J: Fleischner Society: Glossary of terms for
thoracic imaging. Radiology. 246:697–722. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Xu Z, Shi L, Wang Y, Zhang J, Huang L,
Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings
of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu
GM and Zhang LJ: Coronavirus disease 2019 (COVID-19): A perspective
from China. Radiology. 296:E15–E25. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Pan Y and Guan H: Imaging changes in
patients with 2019-nCov. Eur Radiol. 30:3612–3613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Xu YH, Dong JH, An WM, Lv XY, Yin XP,
Zhang JZ, Dong L, Ma X, Zhang HJ and Gao BL: Clinical and computed
tomographic imaging features of novel coronavirus pneumonia caused
by SARS-CoV-2. J Infect. 80:394–400. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu J, Zheng X, Tong Q, Li W, Wang B,
Sutter K, Trilling M, Lu M, Dittmer U and Yang D: Overlapping and
discrete aspects of the pathology and pathogenesis of the emerging
human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J
Med Virol. 92:491–494. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tian S, Hu W, Niu L, Liu H, Xu H and Xiao
SY: Pulmonary pathology of early phase 2019 novel coronavirus
(COVID-19) pneumonia in two patients with lung cancer. J Thorac
Oncol. 15:700–704. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu
SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report
of three COVID-19 cases by minimal invasive autopsies. Zhonghua
Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
46
|
Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan
Y, Nie X, Zhou L, Liu Z, Ren Y, et al: Alveolar macrophage
dysfunction and cytokine storm in the pathogenesis of two severe
COVID-19 patients. EBioMedicine. 57(102833)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Calabrese F, Pezzuto F, Fortarezza F,
Hofman P, Kern I, Panizo A, von der Thüsen J, Timofeev S,
Gorkiewicz G and Lunardi F: Pulmonary pathology and COVID-19:
Lessons from autopsy. The experience of European Pulmonary
Pathologists. Virchows Arch. 477:359–372. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Varga Z, Flammer AJ, Steiger P, Haberecker
M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka
F and Moch H: Endothelial cell infection and endotheliitis in
COVID-19. Lancet. 395:1417–1418. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Xiao F, Tang M, Zheng X, Liu Y, Li X and
Shan H: Evidence for gastrointestinal infection of SARS-CoV-2.
Gastroenterology. 158:1831–1833.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu
HY, Yi F, Yang HC, Fogo AB, Nie X and Zhang C: Renal
histopathological analysis of 26 postmortem findings of patients
with COVID-19 in China. Kidney Int. 98:219–227. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Tabary M, Khanmohammadi S, Araghi F,
Dadkhahfar S and Tavangar SM: Pathologic features of COVID-19: A
concise review. Pathol Res Pract. 216(153097)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Briguglio M, Bona A, Porta M, Dell'Osso B,
Pregliasco FE and Banfi G: Disentangling the hypothesis of host
dysosmia and SARS-CoV-2: The bait symptom that hides neglected
neurophysiological routes. Front Physiol. 11(671)2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Suchonwanit P, Leerunyakul K and
Kositkuljorn C: Cutaneous manifestations in COVID-19: Lessons
learned from current evidence. J Am Acad Dermatol. 83:e57–e60.
2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Chen C, Zhang XR, Ju ZY and He WF:
Advances in the research of cytokine storm mechanism induced by
Corona Virus Disease 2019 and the corresponding immunotherapies.
Zhonghua Shao Shang Za Zhi. 36(E005)2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Nitulescu GM, Paunescu H, Moschos SA,
Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK,
Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to
treat SARS-CoV-2 infection: Mechanistic insights into current
COVID-19 therapies (Review). Int J Mol Med. 46:467–488.
2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ragab D, Salah Eldin H, Taeimah M, Khattab
R and Salem R: The COVID-19 Cytokine Storm; What We Know So Far.
Front Immunol. 11(1446)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Thompson MR, Kaminski JJ, Kurt-Jones EA
and Fitzgerald KA: Pattern recognition receptors and the innate
immune response to viral infection. Viruses. 3:920–940.
2011.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Coperchini F, Chiovato L, Croce L, Magri F
and Rotondi M: The cytokine storm in COVID-19: An overview of the
involvement of the chemokine/chemokine-receptor system. Cytokine
Growth Factor Rev. 53:25–32. 2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhang X, Li S and Niu S: ACE2 and COVID-19
and the resulting ARDS. Postgrad Med J. 96:403–407. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Tortorici MA and Veesler D: Structural
insights into coronavirus entry. Adv Virus Res. 105:93–116.
2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Devaux CA, Rolain JM and Raoult D: ACE2
receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension,
multi-organ failure, and COVID-19 disease outcome. J Microbiol
Immunol Infect. 53:425–435. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gu J, Han B and Wang J: COVID-19:
Gastrointestinal manifestations and potential fecal-oral
transmission. Gastroenterology. 158:1518–1519. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Li YC, Bai WZ and Hashikawa T: The
neuroinvasive potential of SARS-CoV2 may be at least partially
responsible for the respiratory failure of COVID-19 patients. J Med
Virol. 92:552–555. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Li H, Wang YM, Xu JY and Cao B: Potential
antiviral therapeutics for 2019 Novel Coronavirus. Zhonghua Jie He
He Hu Xi Za Zhi. 43(E002)2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
66
|
MacLaren G, Fisher D and Brodie D:
Preparing for the most critically ill patients with COVID-19: The
potential role of extracorporeal membrane oxygenation. JAMA.
323:1245–1246. 2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Chen L, Xiong J, Bao L and Shi Y:
Convalescent plasma as a potential therapy for COVID-19. Lancet
Infect Dis. 20:398–400. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD,
Jin HJ, Tan KS, Wang DY and Yan Y: The origin, transmission and
clinical therapies on coronavirus disease 2019 (COVID-19)
outbreak-an update on the status. Mil Med Res. 7(11)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Becker RC: Covid-19 treatment update:
Follow the scientific evidence. J Thromb Thrombolysis. 50:43–53.
2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Dehelean CA, Lazureanu V, Coricovac D,
Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM and
Cretu O: SARS-CoV-2: Repurposed drugs and novel therapeutic
approaches-insights into chemical structure-biological activity and
toxicological screening. J Clin Med. 9(2084)2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Gautret P, Lagier JC, Parola P, Hoang VT,
Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE,
et al: Hydroxychloroquine and azithromycin as a treatment of
COVID-19: Results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 56(105949)2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Serafin MB, Bottega A, Foletto VS, da Rosa
TF, Hörner A and Hörner R: Drug repositioning is an alternative for
the treatment of coronavirus COVID-19. Int J Antimicrob Agents.
55(105969)2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM,
Lee WJ, Choe KW, Kang YM, Lee B and Park SJ: Case of the index
patient who caused tertiary transmission of COVID-19 Infection in
Korea: The application of lopinavir/ritonavir for the treatment of
COVID-19 infected pneumonia monitored by quantitative RT-PCR. J
Korean Med Sci. 35(e79)2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Lippi G and Plebani M: Laboratory
abnormalities in patients with COVID-2019 infection. Clin Chem Lab
Med. 58:1131–1134. 2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Yang L, Liu S, Liu J, Zhang Z, Wan X,
Huang B, Chen Y and Zhang Y: COVID-19: Immunopathogenesis and
Immunotherapeutics. Signal Transduct Target Ther.
5(128)2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Casadevall A and Pirofski LA: The Ebola
epidemic crystallizes the potential of passive antibody therapy for
infectious diseases. PLoS Pathogens. 11(e1004717)2015.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Wang J, Peng Y, Xu H, Cui Z and Williams
RO III: The COVID-19 vaccine race: Challenges and opportunities in
vaccine formulation. AAPS PharmSciTech. 21(225)2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
